Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.11M | -74.77M | -10.17M | -14.66M | -14.44M |
| Total Depreciation and Amortization | 60.00K | 57.00K | 57.00K | 57.00K | 54.00K |
| Total Amortization of Deferred Charges | 15.00K | 12.00K | 12.00K | 11.00K | 13.00K |
| Total Other Non-Cash Items | -173.00K | 63.85M | -970.00K | 1.42M | 2.45M |
| Change in Net Operating Assets | 3.85M | 71.00K | 4.14M | -4.80M | 597.00K |
| Cash from Operations | -8.36M | -10.78M | -6.93M | -17.98M | -11.33M |
| Capital Expenditure | -33.00K | -16.00K | -- | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 4.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.63M | -137.79M | 14.28M | 708.00K | -12.65M |
| Cash from Investing | -1.66M | -137.80M | 14.28M | 709.00K | -12.65M |
| Total Debt Issued | -- | -- | -- | 5.00M | -- |
| Total Debt Repaid | -1.88M | -- | -- | -- | -- |
| Issuance of Common Stock | 23.46M | 168.46M | 21.00K | 1.26M | 4.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.58M | 168.46M | 21.00K | 6.26M | 4.04M |
| Foreign Exchange rate Adjustments | -3.00K | 3.00K | -1.00K | 4.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.56M | 19.88M | 7.36M | -11.00M | -19.94M |